Article · 29 Dec 2025
Conference abstractPublished 23 Sep 2013
Use of apoptosis assays as tools to compare biosimilarities of anticancer drugs or agents
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The term ?biosimilar? refers to products marketed after expiration of patents and claimed to have similar properties to the existing biologic products. Our laboratory is looking for the potential anticancer drugs or agents to kill breast and colon cancers by initiating apoptosis in these cells. We have used Colo-205 and three highly metastatic breast carcinoma cells (SKBR- 3, MCF-7, and MDA-468) to test the drugs for the biosimilar cause. At least five different cancer-killing agents (D-/L-PPMP, Betulinic Acid, Tamoxifen, and cis-platin) have been identified. All those chemicals killed SKBR-3 and MDA-468 cells by activating caspase-3, -8, or -9 pathways. Caspase-3 pathway is inactive in MCF-7 cells. The degree of apoptosis was evaluated by the fluorescence microscopic studies using PSS-380 dye binding to the phosphatidyl serine excluded on the outer leaflet from the inside of the cells. Varied glycolipid glycosyltransferases were modulated differently during induced apoptosis. However, different agents could not use these parameters for biosimilar comparison because of the unknown mechanisms of gene regulations. On the other hand simple DNA laddering experiments after treatment with biosimilar drugs could be used for quick comparisons of these drugs. In addition to the above agents the apoptotic killing effect of at least three common disialosylgangliosides (GD3, GM1a, and GD1b) were also compared for biosimilar effect.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Subhash Basu”
- BylineArticles whose byline prints “Rui Ma”
- BylineArticles whose byline prints “Manju Basu”
